MSB 3.16% $1.31 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-797

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,820 Posts.
    lightbulb Created with Sketch. 7072
    Guys,

    Read these two articles. Cytokine storms. Evident in MERS, SARS, COVID-19, ARDS, blood clots, heart failure, etc, etc. Its far more complicated than these articles, but they are a good introduction for the lay person. Combined with a bit of biological investigation into how the COVID-19 virus infects ACE-2 cells (which are evident in organs all over the body, not just your lings) and fighting cytokine storms seems an obvious root to take with COVID-19.

    I may be naively hoping for a one size fits all treatment from MSB, but even it it only gets used for ARDS related illnesses arising from COVID-19 (I am desperately hoping it does and then the medical industry begins to investigate wider applications) it is a screaming buy if the recent results get translated into bigger samples (I believe they will as do most of you).

    https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes#

    https://www.knowablemagazine.org/article/health-disease/2020/what-cytokine-storm

    Let the day traders, shorters and rampers debate stock levels and stick to the fundamentals. I missed a crazy selling opportunity via index put options (I was at least short futures) when Korea blew up (this was not a black swan event but a white swan event - predictable) I am not missing the possible rally back on a Aussie company.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.